Sign up today and save up to 67% on a Hartford Courant digital subscription

UnitedHealth Group Inc.

Express Scripts to cover pricey new cholesterol treatments

The nation's biggest pharmacy benefits manager has decided to cover two new drugs that lower artery-clogging cholesterol but raise concern over prices that can top $14,000 a year. Express Scripts said Tuesday that it will pay for prescriptions of Amgen Inc.'s Repatha as well as Praluent from Sanofi and Regeneron Pharmaceuticals Inc. under a few conditions designed to control costs. The decision comes as soaring drug prices draw criticism from patients, doctors and politicians, as well as insurers and employers that generally pay most of the prescription bill. Praluent and Repatha both stirred worry, in particular, because of their potential to be used by millions of patients. ...